1Alcais A, Fieschi C, Abel L, et al. Tuberculosis in children and adults: two distinct generic diseases [J]. J Exp Med, 2005,202(12) : 1617-1621.
2Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm [J]. J Clin Invest, 2009,119(9):2506-2514.
3Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory [J]. EMBO J, 2007,26(4):915-922.
4Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis [J~. Nature Reviews Drug Discov, 2005,5 : 399-411.
5Calandra T, Buca|a R. Macrophage migration inhibitory factor (MIF) : aglucocorticoid counter-regulator within the immune system [J]. Crit Rev Immunol, 1997,17(1) :77-88.
6van Crevel R, Ottenhoff THM, van der Meet WM. Innate immunity to Mycobacterium tuberculosis [J~. Clin Mierobiol Rev, 2002,15(2) :294-309.
7North RJ, Jung YJ. Immunity to tuberculosis [J]. Annu Rev Immunol, 2004,22 : 599-623.
8Bloona BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity [J]. Science, 1966,153 (731) : 80-82.
9David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction [J]. Proc Natl Acad Sci USA, 1966,56(1):72-77.
10Lue H, Kleemann R, Calandra T, et al. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease [J]. Micr Infect, 2002,4(4) :449-460.
